These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31580259)

  • 1. Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation.
    Yu X; Plotnikova O; Bonin PD; Subashi TA; McLellan TJ; Dumlao D; Che Y; Dong YY; Carpenter EP; West GM; Qiu X; Culp JS; Han S
    Elife; 2019 Oct; 8():. PubMed ID: 31580259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM structure of the human neutral amino acid transporter ASCT2.
    Garaeva AA; Oostergetel GT; Gati C; Guskov A; Paulino C; Slotboom DJ
    Nat Struct Mol Biol; 2018 Jun; 25(6):515-521. PubMed ID: 29872227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2.
    Garaeva AA; Guskov A; Slotboom DJ; Paulino C
    Nat Commun; 2019 Jul; 10(1):3427. PubMed ID: 31366933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.
    Garibsingh RA; Ndaru E; Garaeva AA; Shi Y; Zielewicz L; Zakrepine P; Bonomi M; Slotboom DJ; Paulino C; Grewer C; Schlessinger A
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism.
    Scalise M; Pappacoda G; Mazza T; Console L; Pochini L; Indiveri C
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport.
    Scalise M; Pochini L; Console L; Pappacoda G; Pingitore P; Hedfalk K; Indiveri C
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.
    Ndaru E; Garibsingh RA; Shi Y; Wallace E; Zakrepine P; Wang J; Schlessinger A; Grewer C
    J Gen Physiol; 2019 Mar; 151(3):357-368. PubMed ID: 30718375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
    Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA
    Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
    Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.
    Scopelliti AJ; Font J; Vandenberg RJ; Boudker O; Ryan RM
    Nat Commun; 2018 Jan; 9(1):38. PubMed ID: 29295993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
    Yang Z; Follett J; Kerr MC; Clairfeuille T; Chandra M; Collins BM; Teasdale RD
    J Biol Chem; 2018 May; 293(18):6802-6811. PubMed ID: 29563155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of the obligatory exchange mode of human neutral amino acid transporter ASCT2.
    Borowska AM; Chiariello MG; Garaeva AA; Rheinberger J; Marrink SJ; Paulino C; Slotboom DJ
    Nat Commun; 2024 Aug; 15(1):6570. PubMed ID: 39095408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening.
    Colas C; Grewer C; Otte NJ; Gameiro A; Albers T; Singh K; Shere H; Bonomi M; Holst J; Schlessinger A
    PLoS Comput Biol; 2015 Oct; 11(10):e1004477. PubMed ID: 26444490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.
    Ndaru E; Garibsingh RA; Zielewicz L; Schlessinger A; Grewer C
    Biochem J; 2020 Apr; 477(8):1443-1457. PubMed ID: 32242892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
    Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J
    Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of monoclonal antibodies against cell surface domains of ASCT2/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth.
    Suzuki M; Toki H; Furuya A; Ando H
    Biochem Biophys Res Commun; 2017 Jan; 482(4):651-657. PubMed ID: 27865832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.
    Schulte ML; Dawson ES; Saleh SA; Cuthbertson ML; Manning HC
    Bioorg Med Chem Lett; 2015 Jan; 25(1):113-6. PubMed ID: 25435145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.